Whittaker S - Search Results

1

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC.

Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. Olsen EA, et al. Among authors: whittaker s. Blood. 2022 Aug 4;140(5):419-437. doi: 10.1182/blood.2021012057. Blood. 2022. PMID: 34758074 Free PMC article.

2

p53 immunoreactivity is uncommon in primary cutaneous lymphoma.

McGregor JM, Dublin EA, Levison DA, MacDonald DM, Smith NP, Whittaker S. McGregor JM, et al. Among authors: whittaker s. Br J Dermatol. 1995 Mar;132(3):353-8. doi: 10.1111/j.1365-2133.1995.tb08667.x. Br J Dermatol. 1995. PMID: 7718450

3

CD44 variant expression in cutaneous T-cell lymphoma.

Orteu CH, Li W, Allen MH, Smith NP, Barker JN, Whittaker SJ. Orteu CH, et al. Among authors: whittaker sj. J Cutan Pathol. 1997 Jul;24(6):342-9. doi: 10.1111/j.1600-0560.1997.tb00802.x. J Cutan Pathol. 1997. PMID: 9243361

4

Necrobiotic cutaneous T-cell lymphoma.

Woollons A, Darvay A, Khorshid SM, Whittaker S, Jones RR. Woollons A, et al. Among authors: whittaker s. J Am Acad Dermatol. 1999 Nov;41(5 Pt 2):815-9. doi: 10.1016/s0190-9622(99)70332-4. J Am Acad Dermatol. 1999. PMID: 10534657

5

Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN.

Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Scarisbrick JJ, et al. Among authors: whittaker sj. Blood. 2000 May 1;95(9):2937-42. Blood. 2000. PMID: 10779442 Free article.

6

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.

Scarisbrick JJ, Whittaker S, Evans AV, Fraser-Andrews EA, Child FJ, Dean A, Russell-Jones R. Scarisbrick JJ, et al. Among authors: whittaker s. Blood. 2001 Feb 1;97(3):624-30. doi: 10.1182/blood.v97.3.624. Blood. 2001. PMID: 11157477 Free article.

7

A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma.

Scarisbrick JJ, Child FJ, Clift A, Sabroe R, Whittaker SJ, Spittle M, Russell-Jones R. Scarisbrick JJ, et al. Among authors: whittaker sj. Br J Dermatol. 2001 May;144(5):1010-5. doi: 10.1046/j.1365-2133.2001.04191.x. Br J Dermatol. 2001. PMID: 11359390 Clinical Trial.

8

Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response.

Evans AV, Wood BP, Scarisbrick JJ, Fraser-Andrews EA, Chinn S, Dean A, Watkins P, Whittaker SJ, Russell-Jones R. Evans AV, et al. Among authors: whittaker sj. Blood. 2001 Sep 1;98(5):1298-301. doi: 10.1182/blood.v98.5.1298. Blood. 2001. PMID: 11520774 Free article.

9

Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.

Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Scarisbrick JJ, et al. Among authors: whittaker sj. J Invest Dermatol. 2001 Sep;117(3):663-70. doi: 10.1046/j.0022-202x.2001.01460.x. J Invest Dermatol. 2001. PMID: 11564174 Free article.

10

EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer.

Knobler R, Burg G, Whittaker S, Baila L. Knobler R, et al. Among authors: whittaker s. Eur J Cancer. 2002 Mar;38 Suppl 4:S60-4. doi: 10.1016/s0959-8049(01)00466-x. Eur J Cancer. 2002. PMID: 11858967

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

575 results

Search Page